Nyvepria 10 mg /ml Pre-filled syringe

Product Description

Nyvepria 10 mg/ml Pre-filled syringe, featuring the active ingredient Pegfilgrastim, is a vital prescription medication designed to support patients undergoing myelosuppressive anti-cancer chemotherapy.

This advanced biosimilar helps reduce the incidence of febrile neutropenia, a serious complication characterized by fever and a dangerously low white blood cell count, which can lead to life-threatening infections.

Nyvepria works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell crucial for fighting infections.

This product is engineered for ease of use and consistent dosing, provided in a convenient pre-filled syringe format.

For detailed product information and availability, please refer to reputable pharmaceutical platforms such as Nahdi Online, , or .

Benefits of Use

• Significantly reduces the duration of severe neutropenia following chemotherapy.
• Lowers the risk and incidence of febrile neutropenia, thereby preventing severe infections.
• Supports the immune system during cancer treatment, allowing patients to better tolerate chemotherapy cycles.
• Provided in a convenient pre-filled syringe for accurate and consistent dosing.

How to Use

1. Nyvepria is administered as a single subcutaneous injection once per chemotherapy cycle.
2. The injection should be given at least 24 hours after cytotoxic chemotherapy and at least 14 days before the next planned chemotherapy dose.
3. Ensure the syringe is allowed to reach room temperature for 30 minutes before injection; do not warm using heat sources.
4. Inspect the solution for particulate matter and discoloration before administration; it should be clear and colorless.
5. Administer the injection subcutaneously in the abdomen, thigh, or upper arm, rotating injection sites.
6. Follow aseptic technique and dispose of the used syringe in a sharps container.
7. Always follow the specific instructions provided by your healthcare professional.

Caution & Warnings

• This is a prescription-only medication; use only under medical supervision.
• Do not administer Nyvepria within 14 days before or 24 hours after chemotherapy.
• Seek immediate medical attention if you experience signs of an allergic reaction (e.g., rash, hives, difficulty breathing, swelling).
• Report any sudden severe pain in the upper left abdomen or shoulder tip, as this may indicate a serious splenic issue.
• Patients with a history of hypersensitivity to pegfilgrastim or any excipients should not use this product.
• Do not shake the syringe vigorously as this may denature the protein.
• Keep out of reach of children.
• Store in the refrigerator (2°C - 8°C) and protect from light. Do not freeze.

Ingredients

• Active Ingredient: Pegfilgrastim (6 mg per 0.6 ml syringe)
• Excipients: Acetate, Sorbitol, Polysorbate 20, Water for Injection.

Product Details

• Form: Solution for injection in a pre-filled syringe
• Strength: 6 mg / 0.6 ml (equivalent to 10 mg/ml concentration)
• Package Size: Typically one pre-filled syringe per box
• Sterility: Sterile, preservative-free
• Manufacturer: Pfizer